Heart failure occurs when the heart can no longer pump enough blood to meet the body’s needs. Congestive heart failure (CHF) develops gradually as the heart’s pumping ability weakens. It may be right-sided, left-sided, or bilateral.
In right-sided heart failure, the heart cannot effectively pump blood to the lungs for oxygenation. This leads to fluid accumulation in the feet, ankles, legs, liver, abdomen, and the veins of the neck.
In left-sided heart failure, the heart is unable to deliver enough oxygen-rich blood to the rest of the body. Fatigue and shortness of breath are common symptoms.
Approximately 5.7 million Americans have heart failure, with about 400,000 new cases diagnosed each year and roughly 300,000 deaths annually (NHLBI).
Coenzyme Q10 and Heart Failure
There is substantial research showing that patients with CHF may benefit from coenzyme Q10 (CoQ10). Research published in Clinical Investigator found that after three months of CoQ10 supplementation (50–150 mg per day), 54% of patients experienced improvement in at least three symptoms of heart failure. Improvements included:
-
Reduced cyanosis (81%)
-
Reduced edema (76.9%)
-
Less shortness of breath (54%)
-
Fewer arrhythmias (62%)
-
Reduced vertigo (73%)
Other research has shown that lower CoQ10 levels correlate with greater severity of heart failure symptoms, suggesting a relationship between CoQ10 depletion and disease progression.
Carnitine and Heart Failure
Carnitine is another nutrient that appears to be beneficial in CHF. Research published in the American Heart Journal showed that carnitine supplementation over nearly 34 months improved survival rates in patients with congestive heart failure.
Earlier research demonstrated that carnitine could prevent myocardial damage in animal models and improve exercise tolerance in patients with CHF. Additional studies have examined combination therapy.
In a double-blind, placebo-controlled study published in Acta Cardiologica, patients receiving both carnitine and coenzyme Q10 for 12 weeks experienced:
-
Lower levels of inflammatory markers (interleukin-6 and TNF-alpha)
-
Reduced fatigue
-
Improved shortness of breath
These findings suggest that targeted nutritional support may improve functional capacity and symptom burden in patients with congestive heart failure.
